BOSTON, MA, UNITED STATES, February 13, 2025 /EINPresswire / -- When Ruihua Liu founded Hill Research, the goal was clear: to revolutionize clinical trials using Generative AI. With a background in ...

First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable ...

While most cancer research focuses on discovering new treatments, Dr Nicky Lawrence and Professor Nuala Helsby from Waipapa ...

Patient-reported outcomes (PROs) were similar among those treated with tivozanib monotherapy and those given combination ...

India has established itself as a global leader in pharmaceutical production, with potential for further growth through ...

FDA proposes draft guidelines on AI use in drug development, addressing challenges and opportunities for improving safety and ...

Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...

During his tenure, Mr. Lubin grew Ledger Run into a leading technology company in the clinical trial operations market. Driven by Mr. Lubin's vision and leadership, Ledger Run has developed into a ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) ...

An exhibition showing how charity donations are supporting medical research has launched in Leeds. Our Research Story ...

Layoffs, funding freezes, and executive orders spark outcry among federal researchers and university partners, fearing that ...

Ultimately, using ECG data and other alternative datasets throughout key points in the clinical trial life cycle can help researchers achieve more of their goals with less cost, time, and effort.